Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q4 2024 (December 31)6holders +1
2new positions
1sold out
$2.27avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Nomura Holdings Inc. ($1.1M), Sei Investments Co. ($287K) and Bank of New York Mellon Corp ($280K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.2M |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 115,765 shares bought and 33,000 shares sold, net +82,765 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Nomura Holdings Inc. | 0.01% | New | 30,765 | $1.1M |
| Sei Investments Co. | 0.00% | No change | 308,000 | $287K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $280K |
| Cetera Investment Advisers | 0.00% | New | 85,000 | $79K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -8.0% | 81,000 | $75K |
| Stephens Inc. | 0.00% | Reduce -47.9% | 25,000 | $23K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.